http://www.jcog.jp/en/publications/jeog.html Web11 feb 2013 · Briefly, JCOG 0201 failed to demonstrate that a C/T ratio 0.5 or less in T1a-b is precisely predictive of pathologic noninvasiveness. The specificity and sensitivity for these criteria were 96.4% (95% CI, 92.3-98.7) and 30.4% (95% CI, 25.8-35.3), respectively, and they did not reach the hypotheses in the JCOG 0201 study that the lower limit for 95% CI …
Minimally Invasive Function-Preserving Gastrectomy with Sentinel …
http://www.jcog.jp/ Web14 dic 2024 · In contrast, the Japan Clinical Oncology Group (JCOG) also conducted a multicenter prospective trial (JCOG0302) of SN biopsy for cT1N0 gastric cancer . ... World J Surg 2011; 35: 2463–2471. Hiki N, Yamamoto Y, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M, Miki A, Ohyama S, Seto Y: Laparoscopic and endoscopic ... thirdlove activewear
Commentary: Is segmentectomy ready to be accepted as the …
WebJCOG 9516 K Ishida, N Ando, S Yamamoto, et al.: Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus : a Japan Esophageal Oncology Group (JEOG)/ Japan Clinical Oncology Group trial (JCOG9516): Jpn J Clin Oncol 34(10):1-5, 2004. JCOG 9708 H Kato, A Sato, H … WebAffiliations 1 Department of Gastric Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, chuo-ku, Tokyo, 104-0045, Japan. [email protected].; 2 Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.; 3 Department of Surgery, Yokohama City University, Yokohama, Japan.; 4 Department of … Web16 feb 2024 · Background In a phase III study for advanced gastric cancer (AGC), the Japan Clinical Oncology Group (JCOG) 9912 trial, we previously identified the following four prognostic factors—performance status ≥1, number of metastatic sites ≥2, no prior gastrectomy, and abnormal serum alkaline phosphatase levels—and proposed a … thirdlib